Co-Founder and CEO, Damian Wheeler Presents at KSNeurodegen23 on Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid

Angela Prvulovic
May 20, 2023

Thank you to all who joined us at the Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development conference to learn more about our research and the next generation of therapeutic development for neurodegenerative diseases.

Co-Founder and CEO, Damian Wheeler, presented a poster titled "Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid". At Translucence, we have optimized conditions for clearing brains and staining with antibodies to label both microglia and amyloid plaques. Our machine learning-enabled workflows label individual amyloid plaques throughout the brain. For microglia, we have developed two workflows. One labels cell bodies and is used for counting microglia. The other also labels processes to measure changes in shape associated with neuroinflammatory states.

Mapping individual brains to the Allen Brain Atlas allows for quantification of plaques and microglia across 100's of brain regions. Importantly, in 5xFAD Alzheimer's Disease model mice, activated microglia target amyloid plaques and become plaque-associated microglia (PAMs). We have developed workflows for brain-wide labeling and quantification of PAMs throughout the brain.

To learn more, please access our poster here.

Ask your question

Send us your questions and we will get back to you as soon as possible

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

June 15, 2023

Highlights from the 9th Annual BRAIN Initiative Meeting

Translucence Biosystems recently participated in the 9th Annual BRAIN Initiative Meeting: Open Science, New Tools! The conference, held on June 12-13, 2023, aimed to foster a dynamic and collaborative research community through interactions among like-minded scientists who study the brain.
Angela Prvulovic
March 23, 2023

CEO, Damian Wheeler Ph.D., Presents at the BIO-SEE 2023 Webinar Series

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".
Translucence Biosystems
February 20, 2023

Co-founder, Sunil Gandhi Ph.D., Presents at the 20th Annual Advanced Imaging Methods Workshop

Co-Founder, Sunil Gandhi Ph.D., gave a talk entitled "Brain-wide single-cell resolution anatomics" at the recent 20th Annual Advanced Imaging Methods Workshop hosted by the CRL Molecular Imaging Center at the University of California, Berkeley. The talk focused on new statistical methods for handling the hierarchical anatomical definitions of the Allen Brain Atlas.
Translucence Biosystems